5B80 - Overweight and/or Localized Adiposity: Complete ICD-11 Coding Guide

1. Introduction

Overweight and localized adiposity represent clinical conditions of increasing relevance in contemporary medical practice. Code 5B80 of the International Classification of Diseases 11th Revision (ICD-11) encompasses two distinct but related situations: overweight proper, defined by a body mass index (BMI) between 25.0 and 29.9 kg/m² in adults, and localized accumulation of adipose tissue in specific body regions, regardless of the individual's overall BMI.

The clinical importance of this classification lies in the fact that both overweight and localized adiposity can precede the development of frank obesity and its metabolic, cardiovascular, and orthopedic complications. Epidemiological studies demonstrate that the global prevalence of overweight has increased consistently in recent decades, affecting populations of different age groups and socioeconomic contexts.

From a public health perspective, overweight represents a critical transition state where preventive interventions can be particularly effective, preventing progression to obesity and its associated comorbidities. Localized adiposity, in turn, may be associated with specific genetic, hormonal, and metabolic factors that merit individualized attention.

Correct coding using code 5B80 is fundamental for adequate epidemiological recording, health resource planning, longitudinal patient follow-up, and for medical billing and audit purposes. The clear distinction between overweight (5B80) and obesity (5B81) allows for more precise risk stratification and directs appropriate intervention protocols for each stage of the condition.

2. Correct ICD-11 Code

Code: 5B80

Description: Overweight and/or localized adiposity

Parent category: Overweight or obesity

Official definition: Overweight is a condition characterized by excessive adiposity. Overweight is assessed by body mass index (BMI), which is a marker of adiposity calculated as weight (kg)/height² (m²). BMI categories for defining overweight vary by age and sex in infants, children, and adolescents. For adults, overweight is defined by a BMI ranging from 25.0 to 29.9 kg/m². Localized adiposity is a condition characterized by the accumulation of adipose tissue in specific regions of the body, independent of BMI.

This code belongs to the Endocrinology, Nutrition, or Metabolism chapter of ICD-11 and represents a specific diagnostic category that clearly differentiates overweight from established obesity. The inclusion of localized adiposity in the same code recognizes that regional fat accumulation may have important clinical implications even when BMI does not characterize global overweight.

The hierarchical structure of ICD-11 positions this code as a subcategory within the broader spectrum of disorders related to excess body weight, allowing diagnostic specificity without losing the connection to the parent category. This organization facilitates both statistical analysis and clinical understanding of the relationships between different degrees of adiposity.

3. When to Use This Code

Code 5B80 should be used in specific clinical situations that meet the established criteria. Below, we present detailed practical scenarios:

Scenario 1: Adult with BMI between 25.0 and 29.9 kg/m² A 42-year-old patient, 1.75 meters tall and weighing 80 kg, presents with a BMI of 26.1 kg/m². During a routine consultation, the physician identifies this value as indicative of overweight. The patient does not present with established metabolic comorbidities, but there is a family history of type 2 diabetes. In this case, code 5B80 is appropriate for documenting the current condition and initiating preventive strategies.

Scenario 2: Localized abdominal adiposity with normal BMI A 35-year-old female patient with a BMI of 23.5 kg/m² (within the normal range) presents with significant accumulation of abdominal fat with a waist circumference of 92 cm. Laboratory tests reveal incipient insulin resistance. Despite normal BMI, the localized adiposity justifies the use of code 5B80, as this condition has specific metabolic implications and requires monitoring.

Scenario 3: Child or adolescent with overweight according to specific growth curves A 14-year-old adolescent presents with BMI at the 87th percentile for age and sex, according to standardized growth charts. Although the absolute BMI value does not fit adult criteria, the pediatric classification indicates overweight. Code 5B80 is appropriate, considering that criteria vary according to age and sex in pediatric populations.

Scenario 4: Lipedema in early stages A patient presents with disproportionate accumulation of adipose tissue in the lower limbs, with characteristics of lipedema in early stage. The BMI is 27.3 kg/m², characterizing overweight, but the abnormal distribution of fat is the most clinically relevant aspect. Code 5B80 captures both the overweight and the localized adiposity characteristic of this condition.

Scenario 5: Postpartum with weight retention A patient six months after delivery maintains a BMI of 28.4 kg/m², having started pregnancy with a BMI of 22 kg/m². The gestational weight gain was not completely reversed, characterizing current overweight. Code 5B80 documents this condition and guides appropriate nutritional and physical activity interventions.

Scenario 6: Localized accumulation post-hormonal treatment A patient undergoing treatment for hypogonadism develops gynecoid fat accumulation (hip and thigh region) during hormone replacement therapy. The BMI remains at 26.8 kg/m², but the redistribution of body fat is clinically significant. Code 5B80 is appropriate for documenting both the overweight and the localized pattern of adiposity.

4. When NOT to Use This Code

It is essential to recognize situations where code 5B80 is not appropriate, avoiding coding errors that may compromise medical records and epidemiological analyses.

Established obesity: When BMI reaches 30.0 kg/m² or higher in adults, the correct diagnosis is obesity, which should be coded as 5B81, not 5B80. This distinction is critical because obesity and overweight have different prognostic and therapeutic implications.

Edema or fluid retention: Patients with weight gain due to generalized edema, ascites, congestive heart failure, or nephrotic syndrome should not receive code 5B80, as the weight gain is not due to accumulation of adipose tissue, but to fluid retention. These cases require specific codes for the underlying conditions.

Weight gain from muscle mass: Athletes and bodybuilders may present with elevated BMI due to increased muscle mass, not fat. In these cases, code 5B80 would be inappropriate, as there is no excessive adiposity. Assessment of body composition by methods such as bioimpedance or anthropometry is essential for this differentiation.

Pseudoadipose accumulation: Lipomas, which are benign tumors of adipose tissue, should not be coded as localized adiposity. These lesions have a specific code and pathological nature different from physiological fat accumulation.

Specific fat distribution disorders: Conditions such as lipodystrophies (loss or abnormal redistribution of body fat), Cushing syndrome with characteristic fat redistribution, or lipoatrophy associated with antiretroviral medications require specific codes for these distinct clinical entities, not the generic code 5B80.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

The first fundamental step is objective confirmation of diagnosis through precise anthropometric measurements. For adults, calculate BMI by dividing weight in kilograms by height in meters squared. Ensure that the scale is calibrated and that the patient is wearing light clothing without shoes. Height measurement should be performed with an appropriate stadiometer, with the patient in an upright position.

For children and adolescents, in addition to BMI calculation, it is necessary to consult growth curves specific to age and sex, identifying the corresponding percentile. Pediatric overweight is generally defined by BMI between the 85th and 95th percentiles.

In the assessment of localized adiposity, regardless of BMI, perform measurements of body circumferences, especially waist, hip, and waist-to-hip ratio. Waist circumference is particularly important for identifying abdominal adiposity. Also consider assessment by bioimpedance or skinfold thickness to quantify body composition when available.

Step 2: Verify specifiers

Although code 5B80 does not have mandatory extensions in ICD-11, it is important to document relevant clinical characteristics in the medical record. Record the distribution of adiposity (android, gynoid, mixed), the presence of associated comorbidities such as prediabetes, borderline hypertension, or mild dyslipidemia.

Also document identified contributory factors, such as sedentary lifestyle, inadequate dietary pattern, history of recent or progressive weight gain, hormonal factors (menopause, postpartum, subclinical thyroid alterations), use of medications that promote weight gain (corticosteroids, antipsychotics, antidepressants).

The duration of the condition, when known, should be recorded, as long-standing overweight has a higher likelihood of progression to obesity and development of metabolic complications.

Step 3: Differentiate from other codes

The most critical differentiation is with code 5B81 (Obesity). The dividing line is clear: BMI between 25.0 and 29.9 kg/m² characterizes overweight (5B80), while BMI ≥ 30.0 kg/m² defines obesity (5B81). This distinction is not arbitrary; it reflects different levels of cardiovascular and metabolic risk established by robust epidemiological evidence.

For localized adiposity, differentiate from lipodystrophies, which are specific disorders of body fat distribution with distinct pathophysiology, usually of genetic origin or acquired through specific conditions. Lipomas, as mentioned, are benign neoplasms and not physiological fat accumulation.

Also differentiate from conditions that present with increased body volume from other causes: myxedema (hypothyroidism), Cushing syndrome (which has a specific code for the underlying disease), and edematous states of various etiologies.

Step 4: Required documentation

For appropriate coding of 5B80, the medical record must mandatorily contain: current weight in kilograms, height in meters, BMI calculation with explicit numerical result, date of measurement, and clear interpretation indicating overweight when BMI is between 25.0 and 29.9 kg/m².

For cases of localized adiposity, document: measurements of relevant body circumferences (waist, hip, waist-to-hip ratio), description of body fat distribution, results of body composition assessment if performed, and clinical justification for diagnosis when BMI does not characterize overweight.

Also record: presence or absence of associated comorbidities, identified cardiovascular risk factors, guidance provided to the patient regarding lifestyle modifications, and established follow-up plan. This complete documentation not only justifies the coding but also guides continuity of care.

6. Complete Practical Example

Clinical Case

Maria, 38 years old, teacher, presents to the medical office for routine evaluation. She reports that over the past two years she has gained approximately 8 kg, attributing this gain to lifestyle changes during the pandemic, with significant reduction in physical activity and increased consumption of ultra-processed foods. She denies specific symptoms but reports concern about her health, as her mother has type 2 diabetes and her father suffered acute myocardial infarction at age 55.

On physical examination, the patient is in good general condition, blood pressure 128/82 mmHg, heart rate 76 bpm. Anthropometric measurements: weight 72 kg, height 1.65 m, resulting in BMI of 26.4 kg/m². Waist circumference: 86 cm. Hip circumference: 98 cm. Waist-to-hip ratio: 0.88. No edema in lower extremities. General physical examination reveals no other significant abnormalities.

Laboratory tests ordered show: fasting blood glucose 102 mg/dL (upper limit of normal), glycated hemoglobin 5.6% (prediabetes), total cholesterol 215 mg/dL, LDL 138 mg/dL, HDL 48 mg/dL, triglycerides 145 mg/dL. Normal thyroid function (TSH and free T4 within reference values).

Coding Step by Step

Criteria analysis: The BMI of 26.4 kg/m² clearly falls within the overweight range (25.0-29.9 kg/m²), not reaching the obesity threshold (≥30.0 kg/m²). The waist circumference of 86 cm, although not reaching high-risk values, already indicates the beginning of abdominal fat accumulation. The waist-to-hip ratio of 0.88 suggests a mixed distribution pattern with android tendency.

The presence of elevated fasting blood glucose and glycated hemoglobin characterizing prediabetes, associated with borderline lipid profile, confirms that overweight is already having metabolic impact. The family history of diabetes and cardiovascular disease increases the clinical relevance of the overweight diagnosis.

Code selected: 5B80 - Overweight and/or localized adiposity

Complete justification: Code 5B80 is appropriate because the BMI of 26.4 kg/m² fits precisely within the definition of overweight for adults. Although there is beginning of abdominal adiposity, the patient does not present marked localized adiposity that would justify emphasis on this component of the code. The diagnosis is based primarily on the BMI criterion.

Coding with 5B80 allows adequate documentation of this transitional condition, where preventive interventions are crucial to avoid progression to obesity and development of type 2 diabetes. The code also supports longitudinal follow-up and justifies nutritional guidance, prescription of physical activity, and regular metabolic monitoring.

Applicable complementary codes:

Code for prediabetes (5A11), given the glycated hemoglobin of 5.6%
Code for dyslipidemia, if the physician deems pharmacological intervention necessary beyond lifestyle measures

Documentation in the medical record should include the therapeutic plan: nutritional guidance focused on moderate caloric reduction (deficit of 500 kcal/day), prescription of aerobic physical activity (150 minutes weekly), reassessment in three months with new measurement of weight, BMI and control laboratory tests.

7. Related Codes and Differentiation

Within the Same Category

5B81: Obesity

The differentiation between 5B80 (Overweight) and 5B81 (Obesity) is based exclusively on BMI value in adults. Code 5B80 applies when BMI is between 25.0 and 29.9 kg/m², while 5B81 is used when BMI reaches 30.0 kg/m² or higher.

This distinction is not merely numerical; it reflects different stages of adiposity with distinct prognostic implications. Overweight (5B80) represents a state of increased risk, but still modifiable with lifestyle interventions, while obesity (5B81) often requires more intensive therapeutic approaches and is associated with greater risk of established comorbidities.

In clinical practice, a patient with BMI of 29.8 kg/m² receives code 5B80, but if at a subsequent visit their BMI is 30.1 kg/m², the code should be changed to 5B81. This transition marks a critical point in clinical management, potentially justifying more aggressive interventions, including consideration of adjuvant pharmacological therapy.

Differential Diagnoses

Lipedema: A condition characterized by disproportionate and symmetric accumulation of subcutaneous fat in the lower limbs, sparing the feet, predominantly in women. It differs from simple localized adiposity by the presence of pain, increased tenderness, easy bruising, and characteristic progression. Although it may coexist with overweight, lipedema has a specific code when diagnosed.

Lipodystrophies: Disorders characterized by loss or abnormal redistribution of body fat, of genetic or acquired origin. They differ fundamentally from localized adiposity by involving qualitative alterations in fat distribution, not merely quantitative accumulation in specific regions.

Edema: Accumulation of interstitial fluid that may simulate adiposity. It differs by the presence of pitting sign (persistent depression with finger pressure), variation throughout the day, and association with systemic conditions such as cardiac, renal, or hepatic insufficiency.

Metabolic syndrome: Although frequently associated with overweight, it is a distinct diagnostic entity that requires the presence of multiple criteria (abdominal adiposity, hypertension, hyperglycemia, dyslipidemia). A patient may have overweight (5B80) without metabolic syndrome, or have metabolic syndrome with normal BMI but abdominal adiposity.

8. Differences with ICD-10

In ICD-10, overweight was coded as E66.0 - Obesity due to excess calories, without clear distinction between overweight and obesity, or the code R63.5 - Abnormal weight gain was used, which was nonspecific and did not adequately capture the condition of established overweight.

ICD-11 introduces significant changes by creating the specific code 5B80 - Overweight and/or localized adiposity, clearly separating overweight from obesity. This distinction allows greater diagnostic precision and better population risk stratification.

Another important change is the explicit inclusion of localized adiposity in the same code as overweight, recognizing that regional fat accumulation may have clinical relevance independent of overall BMI. In ICD-10, there was no specific code for localized adiposity without obesity.

The hierarchical structure of ICD-11 is also clearer, positioning overweight and obesity as distinct subcategories within the superior category "Overweight or obesity," facilitating epidemiological and clinical analyses. This organization allows both specificity and data aggregation when necessary.

From a practical standpoint, the transition to ICD-11 requires that healthcare professionals familiarize themselves with the new codes and criteria, ensuring that patients with BMI between 25.0 and 29.9 kg/m² are coded as 5B80, no longer using nonspecific codes or the obesity code indiscriminately.

9. Frequently Asked Questions

How is overweight diagnosed?

The diagnosis of overweight in adults is established through the calculation of body mass index (BMI), obtained by dividing weight in kilograms by height in meters squared. Values between 25.0 and 29.9 kg/m² characterize overweight. It is essential that measurements be performed with calibrated equipment, with the patient barefoot and wearing light clothing. For children and adolescents, in addition to BMI calculation, specific percentile tables for age and sex should be consulted. Localized adiposity is diagnosed through measurements of body circumferences, especially waist and hip, and can be complemented by body composition assessment through bioimpedance or skinfold measurements when available.

Is treatment available in public health systems?

The treatment of overweight is primarily based on lifestyle modifications, including nutritional guidance and prescription of physical activity, which are generally available in public health systems through consultations with physicians, nutritionists, and physical education professionals. Many health services offer health education programs and support groups for weight loss. Access to these resources varies according to the organization of each health system, but basic interventions for overweight are generally considered part of essential preventive care and are usually available in primary health care units.

How long does treatment last?

The treatment of overweight has no fixed duration, being more appropriate to consider it as a permanent lifestyle change. Typically, gradual weight loss of 0.5 to 1 kg per week is recommended, which for a person with 10 kg of excess weight would mean a period of 10 to 20 weeks to reach adequate weight. However, follow-up should continue after reaching the goal, as maintaining lost weight requires continuous monitoring and periodic adjustments. Reevaluation consultations are generally scheduled monthly during the active weight loss phase and can be spaced to quarterly or semiannually during the maintenance phase.

Can this code be used in medical certificates?

Yes, code 5B80 can be used in medical certificates when there is a need for work leave or work restrictions related to overweight or its complications. For example, if a worker with overweight develops low back pain that limits work activities, or if there is a need for leave to undergo specialized medical evaluations. However, overweight alone, without complications or functional limitations, generally does not justify work leave. The code is more frequently used in medical records for clinical documentation, longitudinal follow-up, and justification for therapeutic interventions.

Does overweight always progress to obesity?

Not necessarily. Although overweight is a risk factor for the development of obesity, many people remain stable in the overweight range for years or manage to reverse the condition through lifestyle changes. Progression to obesity depends on multiple factors, including continuous energy balance, level of physical activity, genetic factors, hormonal conditions, and behavioral aspects. Early and effective interventions during the overweight phase are particularly important to prevent progression to obesity and its associated complications.

Can localized adiposity occur without overweight?

Yes, localized adiposity can occur in individuals with normal BMI. This situation is recognized in code 5B80, which explicitly includes "localized adiposity... regardless of BMI". Some people present disproportionate distribution of body fat, with accumulation in specific regions such as abdomen, hips, or thighs, even while maintaining total weight within the normal range. This condition may have metabolic implications, especially when it involves visceral abdominal adiposity, which is associated with greater risk of insulin resistance and cardiovascular disease even in people with normal BMI.

What complementary tests are necessary?

For the diagnosis of overweight based on BMI, complementary tests beyond anthropometric measurements are not mandatory. However, in complete clinical evaluation, it is advisable to request laboratory tests to identify metabolic comorbidities and stratify cardiovascular risk. These typically include: fasting glucose and glycated hemoglobin (to assess prediabetes or diabetes), complete lipid profile (total cholesterol, HDL, LDL, triglycerides), liver function (transaminases, to assess hepatic steatosis), thyroid function (TSH, to exclude hypothyroidism), and renal function. In cases of localized adiposity, more detailed hormonal evaluation may be considered if there is suspicion of specific endocrine causes.

How to differentiate overweight from muscle mass gain?

Differentiation is fundamental, especially in athletes and those engaged in intense physical activity. BMI does not distinguish fat mass from lean mass, and may incorrectly classify individuals with high muscle mass as overweight. Assessment of body composition through bioimpedance, skinfold measurements, or more sophisticated methods such as densitometry (DEXA) allows separate quantification of body fat and lean mass. Clinically, individuals with high BMI due to muscle mass present low percentage of body fat, visible muscle definition, increased arm and thigh circumferences due to musculature, and generally engage in regular intense physical activity. In these cases, code 5B80 should not be used.

Conclusion:

Code 5B80 of ICD-11 represents an important advance in the classification of conditions related to excess adiposity, allowing clear distinction between overweight and obesity, in addition to recognizing the clinical relevance of localized adiposity. Precise coding is essential for adequate epidemiological recording, therapeutic planning, and longitudinal follow-up of patients. Health professionals should familiarize themselves with the specific criteria, appropriate use situations, and necessary differentiations to ensure the quality of health information and continuity of care.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Overweight and/or localized adiposity

Compartilhar